Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation
Program
November6(Fri.)
- Opening Remarks
- Keynote Speech Prof. Baron PETER PIOT KCMG MD PhD, Director and Handa Professor of Global Health London School of Hygiene & Tropical Medicine
- Agenda1- Introduction: Overview of COVID-19 Measures
- Agenda2- Inspection of COVID-19 measures and Identification of Issues
- Lunch Session- BD Japan The role of testing in communicable diseases - Learning from COVID-19
- Breakout Session B-1 Optimal COVID-19 test selection based on characteristic of testing method
- Special Speech Audrey Tang, Digital Minister, Taiwan
- Agenda3- Confronting COVID-19 (1): Medical and Social Innovation
- Bill & Melinda Gates Foundation’s Special SessionEmbodiment of "Sanpo-yoshi"- Global Health and the Japanese private sector
November 7(Sat.)
- Keynote Session Dr. Yasuhiro Suzuki, Former Vice-Minister for Health/Chief Medical & Global Health Officer, MHLW, Japan
- Agenda4- Performance of PPP from the Conference and Future Issues
- Special Session I : Challenges in Preventing and Controlling Emerging Infectious Diseases - A look at BIKEN's Vaccine Development Platform
- Special Session II: Expectations for development of COVID-19 vaccines in Japan: Development of an inactivated vaccine by KM Biologics
- Agenda5- Confronting COVID-19 (2): Pharmaceutical and Medical Devices
- Breakout Session A-3 Be confident fighting malaria – Innovative diagnostics towards achieving SDGs
- Special Session III: Speeches from Governors
- Agenda6- Coexisting with COVID-19 〜The Role of Japanese Initiatives
- Summary Session/Conclusion/Statement/General Overview
